Myomo Research Development from 2010 to 2026

MYO Stock  USD 0.73  0.03  3.95%   
Myomo Research Development yearly trend continues to be very stable with very little volatility. Research Development is likely to grow to about 5.8 M this year. During the period from 2010 to 2026, Myomo Research Development quarterly data regression pattern had sample variance of 2.9 T and median of  1,751,731. View All Fundamentals
 
Research Development  
First Reported
2015-03-31
Previous Quarter
M
Current Value
1.5 M
Quarterly Volatility
422.1 K
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Myomo financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Myomo's main balance sheet or income statement drivers, such as Depreciation And Amortization of 938.2 K, Interest Expense of 96.9 K or Selling General Administrative of 10 M, as well as many indicators such as Price To Sales Ratio of 8.16, Dividend Yield of 0.0 or PTB Ratio of 9.3. Myomo financial statements analysis is a perfect complement when working with Myomo Valuation or Volatility modules.
  
Build AI portfolio with Myomo Stock
Check out the analysis of Myomo Correlation against competitors.
Evaluating Myomo's Research Development across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Myomo Inc's fundamental strength.

Latest Myomo's Research Development Growth Pattern

Below is the plot of the Research Development of Myomo Inc over the last few years. It is Myomo's Research Development historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Myomo's overall financial position and show how it may be relating to other accounts over time.
Research Development10 Years Trend
Slightly volatile
   Research Development   
       Timeline  

Myomo Research Development Regression Statistics

Arithmetic Mean2,146,156
Geometric Mean1,629,143
Coefficient Of Variation78.69
Mean Deviation1,274,809
Median1,751,731
Standard Deviation1,688,904
Sample Variance2.9T
Range5.1M
R-Value0.90
Mean Square Error587.7B
R-Squared0.81
Slope300,418
Total Sum of Squares45.6T

Myomo Research Development History

20265.8 M
20255.5 M
20244.8 M
20232.6 M
20222.5 M
20212.6 M
20201.7 M

About Myomo Financial Statements

Myomo investors utilize fundamental indicators, such as Research Development, to predict how Myomo Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
Last ReportedProjected for Next Year
Research Development5.5 M5.8 M

Pair Trading with Myomo

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Myomo position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Myomo will appreciate offsetting losses from the drop in the long position's value.

Moving together with Myomo Stock

  0.72IL3 Integra LifeSciences Earnings Call This WeekPairCorr

Moving against Myomo Stock

  0.45HYB HOYAPairCorr
The ability to find closely correlated positions to Myomo could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Myomo when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Myomo - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Myomo Inc to buy it.
The correlation of Myomo is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Myomo moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Myomo Inc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Myomo can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.
Pair CorrelationCorrelation Matching
When determining whether Myomo Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myomo's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myomo Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myomo Inc Stock:
Check out the analysis of Myomo Correlation against competitors.
You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.
Will Health Care Equipment & Supplies sector continue expanding? Could Myomo diversify its offerings? Factors like these will boost the valuation of Myomo. Expected growth trajectory for Myomo significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Myomo data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Earnings Share
(0.28)
Revenue Per Share
1.015
Quarterly Revenue Growth
0.096
Return On Assets
(0.29)
Return On Equity
(1.01)
The market value of Myomo Inc is measured differently than its book value, which is the value of Myomo that is recorded on the company's balance sheet. Investors also form their own opinion of Myomo's value that differs from its market value or its book value, called intrinsic value, which is Myomo's true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Myomo's market value can be influenced by many factors that don't directly affect Myomo's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Myomo's value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Myomo represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Myomo's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.